Asia Spotlight: Is Double-Digit Growth Sustainable In Emerging Markets?
Executive Summary
A new debate among investors concerns whether double-digit growth is possible across emerging markets or only in China.
You may also be interested in...
Asia Spotlight: China Eclipses Japan To Become Second Largest Pharma Market
Despite a slowdown, China’s pharma market passed Japan in 2013, two years faster than expected.
China Eclipses Japan To Become Second Largest Pharma Market
Despite a slowdown, China’s pharma market passed Japan in 2013, two years faster than expected.
Samsung, Merck Look To Take On Sanofi’s Lantus With Latest Deal
In the latest win for Samsung Bioepis, the Korean company will help develop and manufacture a late-stage insulin glargine candidate with Merck.